Delivery Order SPE2DB22D2007-SPE2DB25FJ3BQ
Award Date 7/17/25
Potential Completion Date 7/18/25
Potential Value $10K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $10,284.07 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a broad-spectrum antibiotic commonly used in military and federal healthcare settings. This firm fixed-price delivery order was competitively awarded without set-aside provisions and is scheduled for completion by August 15, 2025. The award represents a single transaction under AmerisourceBergen's larger contract vehicle with DLA Troop Support Medical. This...
- The Defense Logistics Agency awarded a $11.6K delivery order (Contract No. 4569867824) to AmerisourceBergen Drug Corp for Dalvance 500 mg vials, a specialty antibiotic medication. The order was competitively awarded without set-aside designation and carries a firm fixed price structure with an ultimate completion date of October 30, 2025. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its corporate headquarters as a leading...
- The Defense Logistics Agency awarded a $29,398.41 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic medication used to treat bacterial infections. This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of December 5, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. The...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Dalvance 500 mg vials, with a ceiling value of $2,743.74. The award, issued on September 4, 2025, was competitively awarded with no set-aside designation and is structured as a firm fixed price delivery order with an ultimate completion date of September 5, 2025. Performance will occur at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on October 24, 2025, for the supply of Dalvance 500 mg vials, a specialty antibiotic medication. This firm fixed-price delivery order, valued at $5,719.88 with an ultimate completion date of October 27, 2025, was competitively awarded without set-aside designation. The award represents a child contract under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $8,854.30 to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, an antibiotic pharmaceutical product. This firm fixed price delivery order, issued December 5, 2025, is due for completion by December 8, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the contractor's capability to meet...
- The Defense Logistics Agency awarded a $5,961.05 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dalvance 500 mg vials, with an ultimate completion date of September 10, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical product will be...
- The Defense Logistics Agency awarded a $2,688.81 delivery order to AmerisourceBergen Drug Corp for 500 mg vials of Dalvance, a specialty antibiotic used to treat bacterial skin infections. This firm fixed price delivery order, awarded on May 30, 2025, with completion expected by June 2, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical supply...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 2, 2025, for the supply of Dalvance 500 mg vials with a contract ceiling value of $3,647.09. This is a firm fixed-price delivery order with an ultimate completion date of September 3, 2025, and was funded through the Defense Logistics Agency's Medical Supply Chain. The award was made through competitive procurement with no set-aside designation....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $24,492.53 firm fixed-price delivery order is for the supply of 4567631589 DALVANCE 500 MG VIALS. The contract has an ultimate completion date of March 20, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary...